logo
logo

You're viewing 1 of thousands of funding rounds tracked monthly

Members receive AI-scored leads and instant alerts when companies matching their criteria raise capital. Search all rounds by stage, amount, and investor.

DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program

Jan 24, 2024•over 1 year ago
PowellNanotechnology Research

Description

DNA Nanobots announced the closure of its pre-seed funding round, enabling the launch of its BioPharma Partner Program to streamline end-to-end custom biopharma solutions. The investment will support the development of therapeutics for cancer and rare diseases and facilitate partnerships with BioPharmaceutical companies.

Company Information

Company

DNA Nanobots

Location

Powell, Ohio, United States

About

DNA Nanobots is a platform biotechnology company pioneering the use of functionalized DNA nanoparticles to address challenges associated with targeted delivery of therapeutic payloads. They specialize in engineering custom cell-targeted solutions for partners to deliver drugs, nucleic acids, antibodies, and immunotherapies.

Company News

(2 articles)
Wed, 05 Jun 2024 07:00:00 GMT

Press Release Service: DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas - CRISPR Medicine News

Wed, 24 Jan 2024 08:00:00 GMT

DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program - Business Wire

FundzWatch™ Score

82
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details